Sökning: onr:"swepub:oai:gup.ub.gu.se/251177" >
Outcomes in patient...
-
Sahlen, A.Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.;Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden.;Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore.
(författare)
Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry
- Artikel/kapitelEngelska2016
Förlag, utgivningsår, omfång ...
-
2016-07-19
-
Oxford University Press (OUP),2016
Nummerbeteckningar
-
LIBRIS-ID:oai:gup.ub.gu.se/251177
-
https://gup.ub.gu.se/publication/251177URI
-
https://doi.org/10.1093/eurheartj/ehw284DOI
-
https://lup.lub.lu.se/record/d8224704-ee4d-4f19-bed7-9e2f73a16065URI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-317706URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:135129155URI
Kompletterande språkuppgifter
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Aims Ticagrelor reduces ischaemic events and mortality in acute coronary syndrome (ACS) vs. clopidogrel. We wished to study clinical outcomes in a large real-world population post-ACS. Methods and results We performed a prospective cohort study in 45 073 ACS patients enrolled into SwedishWeb system for Enhancement and Development of Evidence-based care in Heart Disease Evaluated According to Recommended Therapies who were discharged on ticagrelor (N = 11 954) or clopidogrel (N = 33 119) between 1 January 2010 and 31 December 2013. The primary outcome was a composite of all-cause death, re-admission with myocardial infarction (MI) or stroke, secondary outcomes as the individual components of the primary outcome, and re-admission with bleeding. The risk of the primary outcome with ticagrelor vs. clopidogrel was 11.7 vs. 22.3% (adjusted hazard ratio (HR) 0.85 [95% confidence interval: 0.78-0.93]), risk of death 5.8 vs. 12.9% (adjusted HR 0.83 [0.75-0.92]), and risk of MI 6.1 vs. 10.8% (adjusted HR 0.89 [0.78-1.01]) at 24 months. Re-admission with bleeding with ticagrelor vs. clopidogrel occurred in 5.5 vs. 5.2% (adjusted HR 1.20 [1.04-1.40]). In a subset of patients undergoing percutaneous coronary intervention (PCI) on ticagrelor vs. clopidogrel the PCI-related in-hospital bleeding was 3.7 vs. 2.7% (adjusted odds ratio, OR, 1.57 [1.30-1.90]). Conclusion Ticagrelor vs. clopidogrel post-ACS was associated with a lower risk of death, MI, or stroke, as well as death alone. Risk of bleeding was higher with ticagrelor. These real-world outcomes are consistent with randomized trial results.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Varenhorst, ChristophUppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi(Swepub:uu)chrva923
(författare)
-
Lagerqvist, BoUppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)bolager
(författare)
-
Renlund, HenrikUppsala universitet,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)henre358
(författare)
-
Omerovic, Elmir,1968University of Gothenburg,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.(Swepub:gu)xomeel
(författare)
-
Erlinge, DavidLund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Clin Sci, Dept Cardiol, Lund, Sweden.(Swepub:lu)kard-der
(författare)
-
Wallentin, LarsUppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)larswall
(författare)
-
James, Stefan K.Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)stjam367
(författare)
-
Jernberg, T.Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.;Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden.
(författare)
-
Karolinska InstituteKarolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.;Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden.;Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:European Heart Journal: Oxford University Press (OUP)37:44, s. 3335-33420195-668X1522-9645
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Sahlen, A.
-
Varenhorst, Chri ...
-
Lagerqvist, Bo
-
Renlund, Henrik
-
Omerovic, Elmir, ...
-
Erlinge, David
-
visa fler...
-
Wallentin, Lars
-
James, Stefan K.
-
Jernberg, T.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
European Heart J ...
- Av lärosätet
-
Göteborgs universitet
-
Lunds universitet
-
Uppsala universitet
-
Karolinska Institutet